Diseases [C] » Skin and Connective Tissue Diseases [C17] » Skin Diseases » Skin Diseases, Eczematous
Description
Any of a variety of eruptive skin disorders characterized by erythema, oozing, vesiculation, and scaling. Etiology is varied. MeSH
Hierarchy View
Subtype Terms (7)
Dermatitis, Atopic
383 drugs (123 approved, 260 experimental)
Dermatitis, Contact
19 drugs (11 approved, 8 experimental)
Dermatitis, Exfoliative
3 approved drugs
Dermatitis, Seborrheic
32 drugs (25 approved, 7 experimental)
Eczema
127 drugs (63 approved, 64 experimental)
Intertrigo
3 approved drugs
Neurodermatitis
6 drugs (4 approved, 2 experimental)
Approved Indicated Drugs (4)
Phase 4 Indicated Drugs (2)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 2 Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
